Results from the UPITA-Colitis Registry on the Effectiveness and Safety of Upadacitinib in the Induction phase in Patients with Ulcerative Colitis

被引：0
|
作者：
Caballero Mateos, A. M. [1 ]
Gonzalez-Parra, A. C. [2 ]
Gutierrez-Holanda, C. [3 ]
Trapero-Martinez, A. M. [4 ]
Hernandez-Martinez, A. [5 ]
Rojas-Feria, M. [6 ]
Martin-Rodriguez, M. D. M. [7 ]
Rodriguez-Gonzalez, F. J. [8 ]
Saldana, L. [9 ]
Benitez, J. M. [10 ]
Gomez-Delgado, E. [11 ]
Miras, L. [12 ]
Gonzalez, J. [13 ]
Mata, F. J. [14 ]
Olmedo-Martin, R., V [15 ]
GATE, II
机构：
[1] Santa Ana Hosp, Gastroenterol, Motril Granada, Spain
[2] Virgen Macarena Univ Hosp, Gastroenterol, Seville, Spain
[3] San Cecilio Universityl Hosp, Gastroenterol, Granada, Spain
[4] Univ Hosp, Gastroenterol, Jaen, Spain
[5] Torrecardenas Univ Hosp, Gastroenterol, Almeria, Spain
[6] Virgen Rocio Univ Hosp, Gastroenterol, Seville, Spain
[7] Virgen Nieves Univ Hosp, Gastroenterol, Granada, Spain
[8] Virgen Victoria Univ Hosp, Gastroenterol, Malaga, Spain
[9] Costa Sol Hosp, Gastroenterol, Marbella, Spain
[10] Reina Sofia Univ Hosp, Gastroenterol, Cordoba, Spain
[11] Juan Ramon Jimenez Hosp, Gastroenterol, Huelva, Spain
[12] El Poniente Hosp, Gastroenterol, El Ejido, Sri Lanka
[13] Inmaculada Hosp, Gastroenterol, Huercal Overa, Spain
[14] Puerto Real Hosp, Gastroenterol, Puerto Real, Spain
[15] Reg Hosp, Gastroenterol, Malaga, Spain
来源：
JOURNAL OF CROHNS & COLITIS | 2025年 / 19卷
关键词：
D O I：
10.1093/ecco-jcc/jjae190.1284
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P1110
引用
收藏
页码：i2042 / i2044
页数：3
相关论文
共 50 条
  • [41] Tofacitinib Effectiveness and Safety as Therapy for Ulcerative Colitis
    McNally, M.
    Keating, E.
    Gray, E.
    McCormick, E.
    Carroll, A.
    Palmer, C.
    Kennedy, U.
    McKiernan, S.
    MacCarthy, F.
    Dunne, C.
    Hartery, K.
    Egan, L.
    Slattery, E.
    Ryan, B.
    McNamara, D.
    O'Connor, A.
    Breslin, N.
    O'Donnell, S.
    Cullen, G.
    Mulcahy, H.
    Sheridan, J.
    Doherty, G.
    Kevans, D.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I431 - I431
  • [42] Tofacitinib Effectiveness and Safety as Therapy for Ulcerative Colitis
    McNally, M.
    Keating, E.
    Gray, E.
    McCormick, E.
    Carroll, A.
    Palmer, C.
    Kennedy, U.
    McKiernan, S.
    MacCarthy, F.
    Dunne, C.
    Hartery, K.
    Egan, L.
    Slattery, E.
    Ryan, B.
    McNamara, D.
    O'Connor, A.
    Breslin, N.
    O'Donnell, S.
    Cullen, G.
    Mulcahy, H.
    Sheridan, J.
    Doherty, G.
    Kevans, D.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I431 - I431
  • [43] Efficacy and Safety of Upadacitinib Plus Intensive Granulocyte and Monocyte Adsorptive Apheresis as Induction for Intractable Ulcerative Colitis
    Tanida, Satoshi
    Sasoh, Shun
    Otani, Takahiro
    Kubota, Yoshimasa
    Ban, Tesshin
    Ando, Tomoaki
    Nakamura, Makoto
    Joh, Takashi
    JOURNAL OF CLINICAL MEDICINE RESEARCH-CANADA, 2024, 16 (05): : 256 - 263
  • [44] Real-World Comparative Effectiveness and Safety of Filgotinib and Upadacitinib for Ulcerative Colitis: A Multicentre Cohort Study
    Nogami, Akira
    Asonuma, Kunio
    Okabayashi, Shinji
    Ikenouchi, Maiko
    Matsuda, Takahisa
    Shinzaki, Shinichiro
    Fukata, Masayuki
    Kobayashi, Taku
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2024,
  • [45] Efficacy of Upadacitinib in a Randomized Trial of Patients With Active Ulcerative Colitis
    Sandborn, William J.
    Ghosh, Subrata
    Panes, Julian
    Schreiber, Stefan
    D'Haens, Geert
    Tanida, Satoshi
    Siffledeen, Jesse
    Enejosa, Jefferey
    Zhou, Wen
    Othman, Ahmed A.
    Huang, Bidan
    Higgins, Peter D. R.
    GASTROENTEROLOGY, 2020, 158 (08) : 2139 - +
  • [46] Induction of experimental ulcerative colitis by Fusobacterium varium isolated from colonic mucosa of patients with ulcerative colitis
    Ohkusa, T
    Okayasu, I
    Ogihara, T
    Morita, K
    Ogawa, M
    Sato, N
    GUT, 2003, 52 (01) : 79 - 83
  • [47] Cost-Effectiveness Analysis of Upadacitinib in Patients With Moderately to Severely Active Ulcerative Colitis in Greece
    Tzanetakos, Charalampos
    Psarra, Marina
    Kotsis, Ilias
    Gourzoulidis, George
    VALUE IN HEALTH REGIONAL ISSUES, 2025, 46
  • [48] COST-EFFECTIVENESS ANALYSIS OF UPADACITINIB IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS IN GREECE
    Tzanetakos, C.
    Psarra, M.
    Kotsis, I
    Gourzoulidis, G.
    VALUE IN HEALTH, 2023, 26 (12) : S144 - S144
  • [49] The effect of tofacitinib on serum lipids and cardiovascular safety in patients with ulcerative colitis: updated results from the tofacitinib ulcerative colitis clinical programme
    Sands, B. E.
    Taub, P. R.
    Feagan, B. G.
    Armuzzi, A.
    Damiao, A. O.
    Lawendy, N.
    Solano, G.
    Kwok, K.
    Woolcott, J.
    Salese, L.
    Su, C.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S557 - S558
  • [50] THE EFFECT OF TOFACITINIB ON SERUM LIPIDS AND CARDIOVASCULAR SAFETY IN PATIENTS WITH ULCERATIVE COLITIS - UPDATED RESULTS FROM THE TOFACITINIB ULCERATIVE COLITIS CLINICAL PROGRAM
    Sands, Bruce E.
    Taub, Pam R.
    Feagan, Brian G.
    Armuzzi, Alessandro
    Damiao, Aderson O.
    Lawendy, Nervin
    Solano, Gaston
    Kwok, Kenneth
    Woolcott, John
    Salese, Leonardo
    Su, Chinyu
    GASTROENTEROLOGY, 2020, 158 (06) : S1190 - S1190
12345